Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma

Michiro Susa, Arun K. Iyer, Keinosuke Ryu et al. · 2010

Read Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma by Michiro Susa, Arun K. Iyer, Keinosuke Ryu et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010764.txt.

Description

Michiro Susa and colleagues used nanoparticles to disarm drug resistance in bone cancer, in PLOS ONE in 2010. Chemotherapy raised osteosarcoma survival greatly over thirty years. Tumors that return after treatment often resist many drugs at once. A cell pump called ABCB1 throws drugs back out before they can work.

Tiny particles carried silencing RNA into tumor cells to switch off the pump gene. With the pump reduced, standard drugs regained their punch. Delivery is the hard part of RNA medicine, and the particle design matters as much as the message. The approach offers a route for rescuing proven drugs instead of replacing them.

Catalog record

CREATORMichiro Susa, Arun K. Iyer, Keinosuke Ryu et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010764

Browse the full library · About the Tower of Babel